Our research into drug resistance
Cancer is a complex disease both to understand and to treat. One of the greatest challenges facing scientists and doctors is the problem of ‘drug resistance’.
This is where a person's cancer does not respond to a treatment that works well for others with the same disease. In some cases, people develop resistance during the course of their treatment - the drugs that they were initially prescribed stop working.
Cancer Research UK-funded scientists are leading the world in understanding drug resistance and identifying ways to overcome this hurdle. Importantly, this information could also allow doctors in the future to predict who will and who won’t respond well to particular drugs.
Below are some of the highlights of our drug resistance research portfolio
Researcher listing
Jason Carroll
Hormones, drugs and breast cancer
Cancer Research UK Cambridge Institute
Caroline Dive
Developing new cancer treatments
Clinical & Experimental Pharmacology Group
Paterson Institute for Cancer Research
Patrick Johnston
Centre for Cancer Research and Cell Biology
Queen's University Belfast
Simon Mackay
University of Strathclyde
Ultan McDermott
Cancer Genome Project
Wellcome Trust Sanger Institute
David Neal
Better screening and treatment for prostate cancer
Department of Oncology
Cancer Research UK Cambridge Institute
Charles Swanton
Translational Cancer Therapeutics Laboratory
London Research Institute
David Waugh
Improving radiotherapy for prostate cancer
Queen's University Belfast





Read article 